• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1病毒感染因子(Vif)基因多态性对体内小鼠模型中载脂蛋白B mRNA编辑酶催化多肽样3G(A3G)抗病毒活性的影响

The effect of HIV-1 Vif polymorphisms on A3G anti-viral activity in an in vivo mouse model.

作者信息

Cadena Cristhian, Stavrou Spyridon, Manzoni Tomaz, Iyer Shilpa S, Bibollet-Ruche Frederic, Zhang Weiyu, Hahn Beatrice H, Browne Edward P, Ross Susan R

机构信息

Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Department of Microbiology and Immunology, University of Illinois at Chicago College of Medicine, Chicago, IL, 60612, USA.

出版信息

Retrovirology. 2016 Jun 30;13(1):45. doi: 10.1186/s12977-016-0280-y.

DOI:10.1186/s12977-016-0280-y
PMID:27363431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4929759/
Abstract

Humans encode seven APOBEC3 proteins (A-H), with A3G, 3F and 3H as the major factors restricting HIV-1 replication. HIV-1, however, encodes Vif, which counteracts A3 proteins by chaperoning them to the proteasome where they are degraded. Vif polymorphisms found in HIV-1s isolated from infected patients have varying anti-A3G potency when assayed in vitro, but there are few studies demonstrating this in in vivo models. Here, we created Friend murine leukemia viruses encoding vif alleles that were previously shown to differentially neutralize A3G in cell culture or that were originally found in primary HIV-1 isolates. Infection of transgenic mice expressing different levels of human A3G showed that these naturally occurring Vif variants differed in their ability to counteract A3G during in vivo infection, although the effects on viral replication were not identical to those seen in cultured cells. We also found that the polymorphic Vifs that attenuated viral replication reverted to wild type only in A3G transgenic mice. Finally, we found that the level of A3G-mediated deamination was inversely correlated with the level of viral replication. This animal model should be useful for studying the functional significance of naturally occurring vif polymorphisms, as well as viral evolution in the presence of A3G.

摘要

人类编码七种载脂蛋白B mRNA编辑酶催化多肽样蛋白3(APOBEC3)蛋白(A - H),其中A3G、3F和3H是限制HIV - 1复制的主要因素。然而,HIV - 1编码病毒感染因子(Vif),它通过将A3蛋白伴侣转运至蛋白酶体使其降解来对抗A3蛋白。从感染患者分离出的HIV - 1中发现的Vif多态性在体外检测时具有不同的抗A3G效力,但在体内模型中证明这一点的研究很少。在这里,我们构建了编码Vif等位基因的弗氏鼠白血病病毒,这些等位基因先前已显示在细胞培养中能差异中和A3G,或者最初是在原发性HIV - 1分离株中发现的。对表达不同水平人类A3G的转基因小鼠进行感染表明,这些天然存在的Vif变体在体内感染期间对抗A3G的能力有所不同,尽管对病毒复制的影响与在培养细胞中观察到的并不相同。我们还发现,减弱病毒复制的多态性Vif仅在A3G转基因小鼠中恢复为野生型。最后,我们发现A3G介导的脱氨基水平与病毒复制水平呈负相关。这个动物模型对于研究天然存在的Vif多态性的功能意义以及在存在A3G的情况下病毒的进化应该是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/57bf66574ef5/12977_2016_280_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/5f53974a1167/12977_2016_280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/45d7f6d647d8/12977_2016_280_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/57bf66574ef5/12977_2016_280_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/5f53974a1167/12977_2016_280_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/45d7f6d647d8/12977_2016_280_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71b2/4929759/57bf66574ef5/12977_2016_280_Fig3_HTML.jpg

相似文献

1
The effect of HIV-1 Vif polymorphisms on A3G anti-viral activity in an in vivo mouse model.HIV-1病毒感染因子(Vif)基因多态性对体内小鼠模型中载脂蛋白B mRNA编辑酶催化多肽样3G(A3G)抗病毒活性的影响
Retrovirology. 2016 Jun 30;13(1):45. doi: 10.1186/s12977-016-0280-y.
2
APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)和载脂蛋白B mRNA编辑酶催化多肽样蛋白3F(APOBEC3F)协同作用以抑制HIV-1复制。
J Virol. 2016 Apr 14;90(9):4681-4695. doi: 10.1128/JVI.03275-15. Print 2016 May.
3
A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.一种天然存在的 Vif 突变体(I107T)减弱了抗 APOBEC3G 的活性和 HIV-1 的复制。
J Mol Biol. 2013 Aug 23;425(16):2840-52. doi: 10.1016/j.jmb.2013.05.015. Epub 2013 May 23.
4
Long-term passage of Vif-null HIV-1 in CD4 T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.在表达亚致死水平载脂蛋白B mRNA编辑酶催化多肽样蛋白(APOBEC)的CD4 T细胞中长期传代缺乏病毒感染性因子(Vif)的HIV-1,无法产生对APOBEC的抗性。
Virology. 2017 Apr;504:1-11. doi: 10.1016/j.virol.2017.01.016. Epub 2017 Jan 25.
5
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.病毒体共包装胞苷脱氨酶APOBEC3F和APOBEC3G增强HIV限制的机制
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
6
Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.Vif 通过其 5'UTR 对 APOBEC3G mRNA 的翻译调控有助于恢复 HIV-1 感染性。
Sci Rep. 2016 Dec 20;6:39507. doi: 10.1038/srep39507.
7
APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.APOBEC3 降解是 HIV-1 Vif 决定其在髓系细胞系 THP-1 中病毒感染力的主要功能。
mBio. 2023 Aug 31;14(4):e0078223. doi: 10.1128/mbio.00782-23. Epub 2023 Aug 9.
8
Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.HIV-1病毒感染因子(Vif)与人类载脂蛋白B mRNA编辑酶催化多肽样3G(APOBEC3G)蛋白相互作用界面的鉴定。
Cell Rep. 2015 Dec 1;13(9):1789-99. doi: 10.1016/j.celrep.2015.10.068. Epub 2015 Nov 25.
9
Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.莫洛尼白血病病毒 10 型(MOV10)通过干扰 Vif 介导的泛素-蛋白酶体途径抑制 APOBEC3G 的降解。
Retrovirology. 2017 Dec 19;14(1):56. doi: 10.1186/s12977-017-0382-1.
10
An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.一种对拓扑异构酶I无活性的喜树碱类似物,通过抑制Vif依赖的APOBEC3G降解对HIV-1具有广泛的中和作用。
Antiviral Res. 2016 Dec;136:51-59. doi: 10.1016/j.antiviral.2016.11.001. Epub 2016 Nov 5.

引用本文的文献

1
APOBEC3G protects the genome of human cultured cells and mice from radiation-induced damage.APOBEC3G 可保护人类培养细胞和小鼠的基因组免受辐射诱导的损伤。
FEBS J. 2023 Apr;290(7):1822-1839. doi: 10.1111/febs.16673. Epub 2022 Nov 25.
2
Repair of APOBEC3G-Mutated Retroviral DNA Is Facilitated by the Host Enzyme Uracil DNA Glycosylase 2.载脂蛋白 B mRNA 编辑酶催化多肽 3G 突变的逆转录病毒 DNA 的修复是由宿主酶尿嘧啶 DNA 糖基化酶 2 促进的。
J Virol. 2021 Oct 27;95(22):e0124421. doi: 10.1128/JVI.01244-21. Epub 2021 Sep 1.
3
Mouse APOBEC3 Restriction of Retroviruses.

本文引用的文献

1
APOBEC3 Proteins in Viral Immunity.病毒免疫中的载脂蛋白B mRNA编辑酶催化多肽样蛋白3(APOBEC3)家族蛋白
J Immunol. 2015 Nov 15;195(10):4565-70. doi: 10.4049/jimmunol.1501504.
2
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.HIV-1 Vif突变体对APOBEC3G/F的不完全中和促进了从使用CCR5到使用CXCR4的基因进化。
Antimicrob Agents Chemother. 2015 Aug;59(8):4870-81. doi: 10.1128/AAC.00137-15. Epub 2015 Jun 8.
3
Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
鼠 APOBEC3 对逆转录病毒的限制。
Viruses. 2020 Oct 27;12(11):1217. doi: 10.3390/v12111217.
4
Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.鼠白血病病毒 P50 蛋白通过阻止 APOBEC3 的包装来拮抗它。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00032-20.
5
Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.通过核心结合因子β的竞争性结合抑制Vif介导的载脂蛋白B mRNA编辑酶催化多肽样3G降解
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.01708-19.
HIV-1 Vif蛋白的抗载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)活性在精英控制者中减弱。
J Virol. 2015 May;89(9):4992-5001. doi: 10.1128/JVI.03464-14. Epub 2015 Feb 25.
4
APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.载脂蛋白B编辑酶催化多肽3D(APOBEC3D)和载脂蛋白B编辑酶催化多肽3F(APOBEC3F)在人源化小鼠模型中有力地促进了人类免疫缺陷病毒1型(HIV-1)的多样化和进化。
PLoS Pathog. 2014 Oct 16;10(10):e1004453. doi: 10.1371/journal.ppat.1004453. eCollection 2014 Oct.
5
An interleukin-1 beta-encoding retrovirus exhibits enhanced replication in vivo.白细胞介素-1β编码逆转录病毒在体内表现出增强的复制。
J Virol. 2015 Jan;89(1):155-64. doi: 10.1128/JVI.02314-14. Epub 2014 Oct 15.
6
Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.人载脂蛋白B mRNA编辑酶催化多肽样蛋白3A(APOBEC3A)和载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G)在体内对逆转录病毒的不同限制模式
PLoS Pathog. 2014 May 22;10(5):e1004145. doi: 10.1371/journal.ppat.1004145. eCollection 2014 May.
7
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.HIV-1 创始病毒对干扰素-α控制的相对抗性。
Retrovirology. 2013 Dec 3;10:146. doi: 10.1186/1742-4690-10-146.
8
Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.鼠白血病病毒糖基化 Gag 阻止载脂蛋白 B 编辑复合物 3 和细胞质传感器与逆转录复合物的相互作用。
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9078-83. doi: 10.1073/pnas.1217399110. Epub 2013 May 13.
9
HIV restriction by APOBEC3 in humanized mice.APOBEC3 对人源化小鼠体内 HIV 的限制作用。
PLoS Pathog. 2013 Mar;9(3):e1003242. doi: 10.1371/journal.ppat.1003242. Epub 2013 Mar 28.
10
Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.游离或迷失:HIV-1 如何通过其 Vif 蛋白对抗和利用 APOBEC3 诱导的突变。
Viruses. 2012 Nov 14;4(11):3132-61. doi: 10.3390/v4113132.